Answers are grounded in this paper and cite their sources.
Narrative review demonstrates how tobacco smoke worsens tuberculosis progression and treatment outcomes globally, highlighting the necessity of integrated smoking cessation interventions in...
Tuberculosis (TB) and tobacco use are two major global health problems that are concentrated within the same populations, particularly in low- and middle-income countries, and mutually reinforce one another. Tobacco smoke weakens host defence against Mycobacterium tuberculosis by impairing mucociliary clearance, alveolar macrophage function, autophagy, antimicrobial responses, and T-cell-mediated immunity. Epidemiological evidence indicates that active smoking increases the risk of TB infection and disease, while clinical studies associate smoking with a higher bacillary burden, cavitary and extensive pulmonary involvement, delayed microbiological conversion, loss to follow-up, recurrence, and mortality. However, the association between smoking and drug resistance is multifactorial, and evidence supporting direct causality remains limited. Repeated contact with healthcare services during TB treatment provides a unique opportunity to deliver tobacco cessation interventions. Integrating brief counselling, behavioural support, pharmacotherapy, and mobile health interventions into TB programmes may improve both cessation success and long-term TB outcomes. This narrative review summarises current evidence on the epidemiology, biological mechanisms, clinical consequences, and integrated control strategies underlying the relationship between tobacco use and TB.
No takes yet. Share an insight, caveat, or question.
Dülger et al. (2026) studied this question.